Oncosia Scientific attended the 64th Annual Meeting of the Deutsche Gesellschaft für Nuklearmedizin (DGN) in Münster — the company's first exhibition presence at DGN, marking the formal introduction of two new product portfolios to the German market.
At Booth A12, held at the Messe und Congress Centrum Halle Münsterland, Oncosia presented three areas of capability:
PLANET® Dose by DOSIsoft — voxel-based dosimetry for personalised radionuclide therapy, covering ¹⁷⁷Lu, ⁹⁰Y, ¹³¹I, and additional nuclides across MRT and SIRT workflows.
End-to-end dosimetry services for radiopharmaceutical clinical trials — from protocol design and site qualification through centralised analysis and regulatory-grade reporting.
Active reference and calibration products for PET, SPECT, and equipment quality control — distributed in Germany by Oncosia on behalf of Radnostix (formerly RadQual / International Isotopes).
PLANET® Dose is a voxel-based dosimetry solution by DOSIsoft SA, dedicated to targeted radionuclide therapies. It is CE MDR-marked and FDA 510(k) cleared, supporting radionuclides including ¹⁷⁷Lu, ⁹⁰Y, ¹⁶⁶Ho, and ¹³¹I. Learn more at dosisoft.com →
Radnostix (formerly RadQual / International Isotopes) is a US-based manufacturer of active reference and calibration sources for nuclear medicine — supporting PET, SPECT, and equipment quality control programmes worldwide. Oncosia Scientific is the authorised distributor of Radnostix products in Germany. radnostix.com →
Oncosia Scientific GmbH is a German-based specialist in dosimetry for nuclear medicine — providing patient-specific dosimetry services and software solutions for radioligand therapy, SIRT, and radiopharmaceutical trials. As authorised distributor of PLANET® Dose by DOSIsoft, and now of Radnostix calibration and reference products, Oncosia Scientific serves nuclear medicine departments, clinical trial sponsors, and CROs requiring expert-led dosimetry and the measurement infrastructure to support it. www.oncosia.de
Oncosia Scientific · April 2026